Minocycline ameliorates d-galactose-induced memory deficits and loss of Arc/Arg3.1 expression
- 201 Downloads
Dysfunction of learning and memory is widely found in many neurological diseases. Understanding how to preserve the normal function of learning and memory will be extremely beneficial for the treatment of these diseases. However, the possible protective effect of minocycline in memory impairment is unknown. We used the well-established d-galactose rat amnesia model and two behavioral tasks, the Morris water maze and the step-down task, for memory evaluation. Western blot and PCR were used to examine the protein and mRNA levels of Arc/Arg3.1. We report that minocycline supplementation ameliorates both the spatial and fear memory deficits caused by d-galactose. We also found that Arc/Arg3.1, c-fos, and brain-derived neurotrophic factor levels are decreased in the d-galactose animal model, and that minocycline reverses the protein and mRNA levels of Arc in the hippocampus, suggesting the potential role of Arc/Arg3.1 in minocycline’s neuroprotective mechanism. Our study strongly suggests that minocycline can be used as a novel treatment for memory impairment in neurological diseases.
KeywordsMemory deficits Arc d-Galactose
This study was supported by grants from Key Scientific and Technological Projects of Henan Province (No. 122102310072 and No. 122102310155), Scientific and Technological Projects of Zhengzhou (No. 121PPTGG492-4 and No. 121PPTGG492-5).
Compliance with ethical standards
Conflict of interest
The authors have declared that they have no conflict of interest.
- 14.Messaoudi E, Kanhema T, Soule J, Tiron A, Dagyte G, da Silva B, Bramham CR (2007) Sustained Arc/Arg3.1 synthesis controls long-term potentiation consolidation through regulation of local actin polymerization in the dentate gyrus in vivo. J Neurosci 27(39):10445–10455. doi: 10.1523/JNEUROSCI.2883-07.2007 CrossRefPubMedGoogle Scholar
- 18.Zhao Y, Xiao M, He W, Cai Z (2015) Minocycline upregulates cyclic AMP response element binding protein and brain-derived neurotrophic factor in the hippocampus of cerebral ischemia rats and improves behavioral deficits. Neuropsychiatr dis treat 11:507–516. doi: 10.2147/NDT.S73836 PubMedPubMedCentralGoogle Scholar
- 22.Ferretti MT, Allard S, Partridge V, Ducatenzeiler A, Cuello AC (2012) Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer’s disease-like amyloid pathology. J Neuroinflammation 9:62. doi: 10.1186/1742-2094-9-62 CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Carri MT (2008) Minocycline for patients with ALS. Lancet Neurol 7(2):118–119; author reply 120–111. doi: 10.1016/S1474-4422(08)70005-X
- 26.Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, Hilton JF, Spitalny GM, MacArthur RB, Mitsumoto H, Neville HE, Boylan K, Mozaffar T, Belsh JM, Ravits J, Bedlack RS, Graves MC, McCluskey LF, Barohn RJ, Tandan R (2007) Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol 6(12):1045–1053. doi: 10.1016/S1474-4422(07)70270-3 CrossRefPubMedGoogle Scholar
- 27.Sonmez E, Kabatas S, Ozen O, Karabay G, Turkoglu S, Ogus E, Yilmaz C, Caner H, Altinors N (2013) Minocycline treatment inhibits lipid peroxidation, preserves spinal cord ultrastructure, and improves functional outcome after traumatic spinal cord injury in the rat. Spine (Phila Pa 1976) 38(15):1253–1259. doi: 10.1097/BRS.0b013e3182895587 CrossRefGoogle Scholar
- 30.Choi Y, Kim HS, Shin KY, Kim EM, Kim M, Park CH, Jeong YH, Yoo J, Lee JP, Chang KA, Kim S, Suh YH (2007) Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer’s disease models. Neuropsychopharmacology 32(11):2393–2404. doi: 10.1038/sj.npp.1301377 CrossRefPubMedGoogle Scholar
- 31.Fan R, Xu F, Previti ML, Davis J, Grande AM, Robinson JK, Van Nostrand WE (2007) Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. J Neurosci 27(12):3057–3063. doi: 10.1523/JNEUROSCI.4371-06.2007 CrossRefPubMedGoogle Scholar
- 32.Lu J, Wu DM, Zheng YL, Hu B, Zhang ZF, Ye Q, Liu CM, Shan Q, Wang YJ (2010) Ursolic acid attenuates d-galactose-induced inflammatory response in mouse prefrontal cortex through inhibiting AGEs/RAGE/NF-kappaB pathway activation. Cereb Cortex 20(11):2540–2548. doi: 10.1093/cercor/bhq002 CrossRefPubMedGoogle Scholar